Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription

Journal of Virology

Volumn 84, Issue 22, 2010, Pages 11888-11897

  Wang, Jian ^a   Tan, Juan ^a   Guo, Hongyan ^a   Zhang, Qicheng ^a   Jia, Rui ^a   Xu, Xuan ^a   Geng, Yunqi ^a   Qiao, Wentao ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PROTEIN BTAS; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BOVINE FOAMY VIRUS; CELL NUCLEUS; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SPUMA VIRUS; TRANSACTIVATION; VIRUS INFECTION; VIRUS TRANSCRIPTION;

ANIMALS; CATTLE; CATTLE DISEASES; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; PROTEIN BINDING; RETROVIRIDAE INFECTIONS; SPUMAVIRUS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

BOVINE FOAMY VIRUS;

EID: 78049523406     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01036-10     Document Type: Article

References (35)

1. Baldwin, A. S., Jr. 2001. The transcription factor NF-kappaB and human disease. J. Clin. Invest. 107:3-6.
2. Bonizzi, G., and M. Karin. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288. (Pubitemid 38610351)
3. Bren, G. D., N. J. Solan, H. Miyoshi, K. N. Pennington, L. J. Pobst, and C. V. Paya. 2001. Transcription of the RelB gene is regulated by NF-kappaB. Oncogene 20:7722-7733.
4. Broussard, S. R., A. G. Comuzzie, K. L. Leighton, M. M. Leland, E. M. Whitehead, and J. S. Allan. 1997. Characterization of new simian foamy viruses from African nonhuman primates. Virology 237:349-359.
5. Dejardin, E., N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, and D. R. Green. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525-535.
6. Delelis, O., J. Lehmann-Che, and A. Saib. 2004. Foamy viruses - a world apart. Curr. Opin. Microbiol. 7:400-406.
7. Do, R. K., E. Hatada, H. Lee, M. R. Tourigny, D. Hilbert, and S. Chen-Kiang. 2000. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192:953-964.
8. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl.):S81-S96.
9. Habraken, Y., and J. Piette. 2006. NF-kappaB activation by double-strand breaks. Biochem. Pharmacol. 72:1132-1141.
10. Hatada, E. N., D. Krappmann, and C. Scheidereit. 2000. NF-kappaB and the innate immune response. Curr. Opin. Immunol. 12:52-58.
11. Hatama, S., K. Otake, S. Omoto, Y. Murase, A. Ikemoto, M. Mochizuki, E. Takahashi, H. Okuyama, and Y. Fujii. 2001. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. J. Gen. Virol. 82:2999-3004.
12. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18:2195-2224.
13. Herchenroder, O., R. Renne, D. Loncar, E. K. Cobb, K. K. Murthy, J. Schneider, A. Mergia, and P. A. Luciw. 1994. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201:187-199.
14. Hill, C. L., P. D. Bieniasz, and M. O. McClure. 1999. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80(Pt. 8):2003-2009.
15. Hiscott, J., H. Kwon, and P. Genin. 2001. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J. Clin. Invest. 107:143-151.
16. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-663.
17. Kucharczak, J., M. J. Simmons, Y. Fan, and C. Gelinas. 2003. To be, or not to be: NF-kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22:8961-8982.
18. Lanoix, J., J. Lacoste, N. Pepin, N. Rice, and J. Hiscott. 1994. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway. Oncogene 9:841-852.
19. Lecellier, C. H., M. Neves, M. L. Giron, J. Tobaly-Tapiero, and A. Saib. 2002. Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J. Virol. 76:7220-7227.
20. Lernbecher, T., U. Muller, and T. Wirth. 1993. Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770. (Pubitemid 23339886)
21. Linial, M. 2000. Why aren't foamy viruses pathogenic? Trends Microbiol. 8:284-289.
22. Liu, S., H. Chen, J. Chen, D. Liang, Q. Chen, Y. Geng, and C. Wood. 1997. Isolation and identification of a bovine spuma virus isolate 3026. Bing Du Xue Bao 13:140-145. (In Chinese.)
23. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
24. Materniak, M., L. Bicka, and J. Kuzmak. 2006. Isolation and partial characterization of bovine foamy virus from Polish cattle. Pol. J. Vet. Sci. 9:207-211.
25. Murray, S. M., and M. L. Linial. 2006. Foamy virus infection in primates. J. Med. Primatol. 35:225-235.
26. Paine, E., R. I. Scheinman, A. S. Baldwin, Jr., and N. Raab-Traub. 1995. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins. J. Virol. 69:4572-4576.
27. Ryseck, R. P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol. Cell. Biol. 12:674-684.
28. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499. (Pubitemid 32801552)
29. Tak, P. P., and G. S. Firestein. 2001. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107:7-11.
30. Tan, J., W. Qiao, J. Wang, F. Xu, Y. Li, J. Zhou, Q. Chen, and Y. Geng. 2008. IFP35 is involved in the antiviral function of interferon by association with the viral Tas transactivator of bovine foamy virus. J. Virol. 82:4275-4283. (Pubitemid 351563665)
31. Tobaly-Tapiero, J., P. Bittoun, M. Neves, M. C. Guillemin, C. H. Lecellier, F. Puvion-Dutilleul, B. Gicquel, S. Zientara, M. L. Giron, H. de The, and A. Saib. 2000. Isolation and characterization of an equine foamy virus. J. Virol. 74:4064-4073. (Pubitemid 30214411)
32. Veiby, O. P., and M. A. Read. 2004. Chemoresistance: impact of nuclear factor (NF)-kappaB inhibition by small interfering RNA. Commentary re J. Guo et al., Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the NF-kappaB p65 subunit. Clin. Cancer Res. 2004;10:3333-3341. Clin. Cancer Res. 10:3262-3264.
33. Vogel, C. F., E. Sciullo, W. Li, P. Wong, G. Lazennec, and F. Matsumura. 2007. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol. Endocrinol. 21:2941-2955.
34. Wang, J., J. Tan, X. Zhang, H. Guo, Q. Zhang, T. Guo, Y. Geng, and W. Qiao. 2010. BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription. Virology 400:215-223.
35. Williams, S. A., H. Kwon, L. F. Chen, and W. C. Greene. 2007. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J. Virol. 81:6043-6056.